IP Library Granted Patent US 11,723,845
Granted Patent B2
US 11,723,845 · App. 17/465,574 · Granted Aug 15, 2023

Cosmetic compositions and uses thereof

Inventors: Tiffany Florence (Dallas, TX); Michelle Hines (Hickory Creek, TX); David Gan (Southlake, TX)
Assignee: MARY KAY INC.
A61K8/04A61K8/365A61K8/4953A61K8/602A61K8/922A61K8/9711A61K8/9789A61Q19/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,723,845
App. No.
17/465,574
Granted
Aug 15, 2023
Kind
B2
Abstract

Disclosed is a method for reducing the appearance of cellulite, improving the texture of skin, or reducing the appearance of a fine line or wrinkle in skin that has cellulite, rough skin texture, or a fine line or wrinkle, the method comprising topically applying a composition to the skin that includes effective amounts of caffeine, escin, and an extract from Ascophyllum nodosum , wherein topical application of the composition reduces the appearance of cellulite, improves the texture of the skin, or reduces the appearance of the fine line or wrinkle.

Claims (79)

1. A method for reducing the appearance of cellulite, improving the texture of skin, or reducing the appearance of a fine line or wrinkle in a target region of skin that has cellulite, rough skin texture, or a fine line or wrinkle, the method comprising topically applying a composition to the target region that includes caffeine, escin, lecithin, and an extract from Ascophyllum nodosum , wherein topical application of the composition reduces the appearance of cellulite, improves the texture of the skin, or reduces the appearance of the fine line or wrinkle.

2. The method of claim 1 , wherein the composition comprises 0.0001 to 10% by weight of a combination of caffeine, escin, and the extract from Ascophyllum nodosum.

3. The method of claim 1 , wherein the composition further comprises:

water;

pentylene glycol;

fructose;

glycerin;

phenoxyethanol;

xanthan gum;

sodium PCA;

sodium lactate;

glycine;

urea; and

inositol.

4. The method of claim 1 , wherein the composition further comprises:

water;

glycerin;

hydrogenated vegetable oil;

Triticum vulgare (wheat) germ oil;

Prunus persica (peach) kernel oil;

cyclopentasiloxane;

phenoxyethanol;

coco-caprylate/caprate;

beeswax;

magnesium/aluminum hydroxide stearate;

butylene glycol;

caprylyl glycol;

bisabolo; and

sodium hyaluronate.

5. The method of claim 1 , wherein the composition further comprises:

water;

Butyrospermum parkii (shea butter); and

Cocos nucifera (coconut) oil.

6. The method of claim 1 , wherein the composition further comprises:

cetearyl alcohol;

glycerin;

glyceryl stearate;

Helianthus annuus (sunflower) seed oil;

stearic acid;

Oenothera biennis (evening primrose) oil;

Vitis vinifera (grape) seed oil;

tocopherol;

tocopheryl acetate;

isopropyl palmitate; and

phenoxyethanol.

7. The method of claim 1 , wherein the composition further comprises:

water;

glycerin;

propylene glycol;

Helianthus annuus (sunflower) seed oil;

hydrogenated coconut oil;

caprylic/capric triglyceride;

tocopheryl acetate;

sodium hyaluronate;

Butyrospermum parkii (shea) butter;

panthenol;

dipotassium glycyrrhizate;

squalene;

pentylene glycol;

phenoxyethanol;

benzyl alcohol;

xanthan gum;

squalene; and

tocopherol.

8. The method of claim 1 , wherein the composition further comprises:

water; and

alcohol.

9. The method of claim 1 , wherein the composition increases skin firmness or elasticity in said target region.

10. The method of claim 1 , wherein the composition increases lipolysis in adipocytes.

11. The method of claim 1 , wherein the composition decreases maturation of fat cells.

12. The method of claim 1 , wherein the target region comprises a dimple, and wherein the composition reduces the appearance of the dimple.

13. The method of claim 12 , wherein the composition reduces the difference between the peak and valley of the dimple.

14. The method of claim 1 , wherein the composition decreases the size of adipocytes in the target region.

15. The method of claim 14 , wherein at least some of the adipocytes in the target region have a diameter of 40 μm-160 μm.

16. The method of claim 15 , wherein between 5 and 20% of the adipocytes in the target region are decreased in size.

17. The method of claim 1 , wherein the composition increases the epidermal thickness of skin in the target region between 5 and 50%.

18. The method of claim 1 , wherein the composition increases triglyceride release from adipocytes in the target region.

19. The method of claim 1 , wherein the composition is formulated as a cream, lotion, or gel.

20. The method of claim 1 , wherein the composition is formulated as an emulsion.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2022
From: BELAJ INNOVATIONS, LLC
To: MARY KAY INC.
Reel/Frame 062144/0439 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2021
From: FLORENCE, TIFFANY; HINES, MICHELLE; GAN, DAVID
To: MARY KAY INC.
Reel/Frame 057375/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2021
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 057375/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2021
From: ALLUSTRA TECHNOLOGIES LLC
To: BELAJ INNOVATIONS LLC
Reel/Frame 057375/0981 →